Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Mackay

Showing results (161-170 of 249) with videos related to

Pageof 25
Sort By:
Human Molecular Genetics|October 11, 2012
Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomasIvana Kurelac, Alan MacKay, Maryou B K Lambros, et al.
Scientific Reports|January 20, 2018
The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusionAnna Burford, Alan Mackay, Sergey Popov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumorsRaisa Vuononvirta, Neil J Sebire, Anthony R Dallosso, et al.
Cancer Research|February 25, 2010
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerNicholas Turner, Alex Pearson, Rachel Sharpe, et al.
Journal of Alzheimer'S Disease : JAD|June 5, 2009
Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individualsHamid R Sohrabi, Kristyn A Bates, Mark Rodrigues, et al.
Breast Cancer Research and Treatment|August 19, 2009
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancersRachael Natrajan, Britta Weigelt, Alan Mackay, et al.
The Journal of Pathology|March 12, 2014
Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour modelsLorenzo Melchor, Gemma Molyneux, Alan Mackay, et al.
The Journal of Pathology|May 13, 2015
Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survivalFranziska Baenke, Sébastien Dubuis, Charlene Brault, et al.
The Journal of Pathology|August 12, 2009
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysisCaterina Marchiò, Maryou B Lambros, Patrizia Gugliotta, et al.
Oncogene|May 6, 2003
cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cellsAlan Mackay, Chris Jones, Tim Dexter, et al.
Pageof 25

Showing results (161-170 of 249) with videos related to

Sort By:
Pageof 25
Human Molecular Genetics|October 11, 2012
Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomasIvana Kurelac, Alan MacKay, Maryou B K Lambros, et al.
Scientific Reports|January 20, 2018
The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusionAnna Burford, Alan Mackay, Sergey Popov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumorsRaisa Vuononvirta, Neil J Sebire, Anthony R Dallosso, et al.
Cancer Research|February 25, 2010
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerNicholas Turner, Alex Pearson, Rachel Sharpe, et al.
Journal of Alzheimer'S Disease : JAD|June 5, 2009
Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individualsHamid R Sohrabi, Kristyn A Bates, Mark Rodrigues, et al.
Breast Cancer Research and Treatment|August 19, 2009
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancersRachael Natrajan, Britta Weigelt, Alan Mackay, et al.
The Journal of Pathology|March 12, 2014
Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour modelsLorenzo Melchor, Gemma Molyneux, Alan Mackay, et al.
The Journal of Pathology|May 13, 2015
Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survivalFranziska Baenke, Sébastien Dubuis, Charlene Brault, et al.
The Journal of Pathology|August 12, 2009
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysisCaterina Marchiò, Maryou B Lambros, Patrizia Gugliotta, et al.
Oncogene|May 6, 2003
cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cellsAlan Mackay, Chris Jones, Tim Dexter, et al.
Pageof 25